 |
市場調査レポート
商品コード
1452798
RNA分析の世界市場規模、シェア、成長分析、技術別、製品別、用途別 - 産業予測（2024～2031年）Global RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR Technology, Microarray Technology), By Product, By Application - Industry Forecast 2024-2031 |
||||||
| RNA分析の世界市場規模、シェア、成長分析、技術別、製品別、用途別 - 産業予測（2024～2031年） |
|
出版日: 2024年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界のRNA分析市場規模は2022年に155億米ドルと評価され、2023年の161億2,000万米ドルから2031年には220億6,000万米ドルに成長し、予測期間中（2024～2031年）のCAGRは4.00%で成長する見通しです。
この市場は、がん、骨粗しょう症、貧血など、人口のかなりの部分に蔓延している慢性疾患を管理するためにミネラルサプリメントを採用する人が増えていることを背景に急成長しています。大手製薬会社は、より健康的なライフスタイルとサプリメントの使用を促進するための社会的キャンペーンに積極的に取り組んでいます。例えば、2023年2月、Torrent Pharmaceuticals Ltdは、カルシウム不足とその日常生活への影響についての認識を高めることを目的としたTVキャンペーン#BeShelcalStrongを開始しました。座りっぱなしのライフスタイルや不健康な食生活の増加により、栄養不足に直面する人が増え、疲労、骨の弱さ、免疫システムの低下などの問題が生じています。より健康的なライフスタイルを推進する政府の取り組みは、市場の成長にさらに貢献しています。主なプレーヤーは革新的な製品開発に注力し、エキゾチックな原料を探求しており、植物由来の製品の人気がさらなる成長機会をもたらしています。COVID-19が大流行するなか、このウイルスがミネラル不足の人々に不釣り合いな影響を与えたという調査結果が出たため、ミネラル補助食品の需要が増加しました。このような前向きな動向にもかかわらず、経済危機や政治紛争がサプライチェーンを混乱させ、現地生産された安価な商品の拡散につながることから、市場は偽造品販売による課題に直面しています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
RNA分析の世界市場：技術別
- 市場概要
- リアルタイムPCR（qPCR）テクノロジー
- マイクロアレイ技術
- シーケンス技術
- その他
RNA分析の世界市場：製品別
- 市場概要
- 機器
- キットと試薬
- CHOメディア miRNAおよびsiRNA
- 逆転写酵素とRT-PCR
- RNAの抽出と精製
- RNA干渉
- その他
- サービス
RNA分析の世界市場：用途別
- 市場概要
- RNA発現アトラスの構築
- エピジェネティクス
- 感染症と病因
- 選択的 RNAス価格
- RNAの構造と分子動力学
- RNA治療薬の開発と提供
- その他
RNA分析の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Thermo Fisher Scientific Inc.（USA）
- Illumina, Inc.（USA）
- Agilent Technologies, Inc.（USA）
- Qiagen AG（Germany）
- PerkinElmer, Inc.（USA）
- Eurofins Scientific SE（Luxembourg）
- Genewiz（a Brooks Life Sciences Company）（USA）
- Bio-Rad Laboratories, Inc.（USA）
- Merck KGaA（Germany）
- Promega Corporation（USA）
- Fluidigm Corporation（USA）
- Oxford Nanopore Technologies Ltd.（United Kingdom）
- Takara Bio Inc.（Japan）
- Zymo Research Corporation（USA）
- BGI Group（China）
- NuGEN Technologies, Inc.（USA）
- Lexogen GmbH（Austria）
- Pacific Biosciences of California, Inc.（USA）
- Roche Diagnostics（Switzerland）
- Bio-Techne Corporation（USA）
Global RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).
The market is experiencing a surge driven by the growing adoption of mineral supplements to manage chronic conditions prevalent in a significant portion of the population, such as cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical companies are actively engaging in social campaigns to promote healthier lifestyles and supplement usage. For instance, in February 2023, Torrent Pharmaceuticals Ltd launched the TV campaign #BeShelcalStrong, aiming to raise awareness about calcium deficiency and its impact on daily life. The rise in sedentary lifestyles and unhealthy diets has resulted in more people facing nutritional deficiencies, leading to issues like fatigue, weak bones, and compromised immune systems. Government initiatives promoting healthier lifestyles further contribute to market growth. Key players are focusing on innovative product development and exploring exotic ingredients, while the popularity of plant-based products presents additional growth opportunities. Amid the COVID-19 pandemic, mineral supplements witnessed increased demand, as research indicated the virus disproportionately affected individuals with mineral deficiencies. Despite this positive trend, the market faces challenges from counterfeit product sales, driven by economic crises and political conflicts disrupting the supply chain and leading to the proliferation of locally produced, inexpensive items.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global RNA Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global RNA Analysis Market Segmental Analysis
The global RNA analysis market is segmented on the basis of technology, product, application, end - use, region. By technology, the market is segmented real time-pcr (QPCR) technology, microarray technology, sequencing technology, and others. By product, the market is segmented into instruments, kits & reagents, cho media mirna & sirna, reverse transcriptases & rt-pcr, rna interference, rna extraction & purification, others, services. By application, the market is segmented into construction of rna expression atlas, infectious diseases & pathogenesis, epigenetics, alternative rna splicing, rna structure & molecular dynamics, development & delivery of rna therapeutics, others. By end - use, the market is segmented into government institutes & academic centers, contract research organizations (CROs), pharmaceutical & biotechnology companies, hospitals & clinics. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global RNA Analysis Market
The pharmaceutical and biotech industries extensively depend on RNA analysis for the advancement of targeted therapies, personalized medicine, and novel drug candidates. This heightened reliance has generated significant demand for RNA analysis techniques within these sectors.
Restraints in the Global RNA Analysis Market
Analyzing RNA sequencing data requires intricate bioinformatics expertise and resources, posing a potential barrier to its widespread adoption in certain environments. The complexity of the process may limit accessibility and implementation in settings where specialized skills and dedicated resources may be scarce.
Market Trends of the Global RNA Analysis Market
The progress in long-read sequencing technologies has empowered the precise sequencing of entire RNA molecules, thereby advancing our comprehension of alternative splicing, isoforms, and intricate gene structures.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global RNA Analysis Market by Technology
- Market Overview
- Real Time-PCR (qPCR) Technology
- Microarray Technology
- Sequencing Technology
- Others
Global RNA Analysis Market by Product
- Market Overview
- Instruments
- Kits & Reagents
- CHO Media miRNA & siRNA
- Reverse Transcriptases & RT-PCR
- RNA Extraction & Purification
- RNA Interference
- Others
- Services
Global RNA Analysis Market by Application
- Market Overview
- Construction of RNA Expression Atlas
- Epigenetics
- Infectious Diseases & Pathogenesis
- Alternative RNA Splicing
- RNA Structure & Molecular Dynamics
- Development & Delivery of RNA Therapeutics
- Others
Global RNA Analysis Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genewiz (a Brooks Life Sciences Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Nanopore Technologies Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zymo Research Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NuGEN Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lexogen GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pacific Biosciences of California, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
